Evidence map›Paper›PMID 11024187›Full record

ArticleNucleic acids research2000

Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

J A Coronella, P Telleman, T D Truong, F Ylera, R P Junghans

Abstract read
In one paragraph

Article in Nucleic acids research, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Technologies for Monoclonal Antibody Discovery and Development.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  11. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  12. Article
  13. Single B cell antibody technologies.New biotechnology · 2011
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J A CoronellaBiotherapeutics Development Lab, Harvard Institute of Human Genetics, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
P Telleman
T D Truong
F Ylera
R P Junghans
Beth Israel Deaconess Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amplification of human immunoglobulin has many potential applications such as analysis of clonality, isolation of immunogenic antigens and antigen-specific immunotherapy. Here we describe a method for amplification of human immunoglobulin heavy and light chains from single B lymphocytes or plasma cells. Cells are isolated by FACS, and Ig is amplified by semi-nested RT-PCR. The method is versatile, sensitive and reliable: it provides appropriately paired heavy and light chains, requiring as little as 2 days to produce amplified Fab DNA from human tissues.

Indexed as

Base SequenceB-LymphocytesBreast NeoplasmsCell SeparationDNA PrimersEquipment ContaminationFemaleFlow CytometryHumansImmunoglobulin Fab FragmentsImmunoglobulin FragmentsImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Variable RegionDNA PrimersImmunoglobulin Fab FragmentsImmunoglobulin FragmentsImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Variable RegionRNA, Messenger

Identifiers

PMID11024187
PMCPMC110801
OpenAlexW2129481624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.